InvestorsHub Logo

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Live Updating
profile icon
docrew0 Free
10/30/06 5:46 PM
profile icon
docrew0 Free
10/25/06 4:16 PM
profile icon
biobio Free
01/11/06 10:31 PM
profile icon
ronpopeil Free
01/11/06 8:47 PM
profile icon
biobio Free
01/11/06 8:15 PM
profile icon
docrew0 Free
01/09/06 12:50 AM
profile icon
smd1234 Free
01/08/06 6:31 PM
profile icon
docrew0 Free
01/08/06 3:36 PM
profile icon
biobio Free
01/08/06 3:31 PM
profile icon
biobio Free
01/08/06 3:29 PM
profile icon
docrew0 Free
01/08/06 2:31 PM

Sirna Therapeutics (RNAI) RSS Feed

Followers
6
Posters
4
Posts (Today)
0
Posts (Total)
11
Created
01/08/06
Type
Free
Moderators
Sirna Therapeutics is a clinical-stage biotechnology company developing RNAi-based therapies for serious diseases and conditions, including age- related macular degeneration (AMD), hepatitis B and C, dermatology, asthma, Huntington's disease, diabetes and oncology. Sirna Therapeutics has presented interim Phase 1 clinical trial data for its most advanced compound, Sirna-027, a chemically optimized siRNA targeting the clinically validated vascular endothelial growth factor pathway to treat AMD. Sirna-027, which has been partnered with Allergan, Inc., continues to demonstrate that it is safe and well tolerated with 100% of patients showing visual acuity stabilization after eight weeks from a single injection. In addition, Sirna recently announced that it has selected Sirna-AV34, a systemically delivered, optimized siRNA compound, as its candidate for advancement to human clinical testing against Hepatitis C virus. Sirna has a leading intellectual property portfolio in RNAi with 48 issued patents and over 250 pending applications worldwide. More information on Sirna Therapeutics is available on the Company's web site at http://www.sirna.com.
15 min PBS Nova overview Blindness Hepatitis Partnerships Worldwide Patent Listings USPTO Patent Collection
Latest USPTO Patent Applications Charts Insider Trading Latest SEC Filings Company news Related developments
Volume:
Day Range:
Last Trade Time:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
RNAI Latest News
  • No Recent News Available for this company!
New Post